|
Q4 2017
Filed on Feb 12, 2018
|
358,868
|
$5.6 - $9.9
$2.01M - $3.55M
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
34,703
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
1,155,500
|
N/A
|
|
Dimension Therapeutics Inc
|
Q4 2017
Filed on Feb 12, 2018
|
1,688,870
|
N/A
|
|
Woori Bk Glbl Medium Term Su
|
Q3 2017
Filed on Nov 13, 2017
|
62,600,000
|
N/A
|
|
Royal Bk Scotland Group PLC
|
Q3 2017
Filed on Nov 13, 2017
|
6,300,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
364,719
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
148,452
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
373,571
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
4,100,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
3,050,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
14,150,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
66,541
|
$3.2 - $20.8
$213K - $1.38M
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
30,563
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
150,879
|
$18.0 - $32.95
$2.72M - $4.97M
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
104,400
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
102,864
|
$12.7 - $15.0
$1.31M - $1.54M
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
319,305
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
75,813
|
$11.96 - $16.95
$907K - $1.29M
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
861,623
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
209,198
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
5,459
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
832,224
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
3,000,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
2,265
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
1,000,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
1,900,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
738,913
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
3,946,169
|
N/A
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 13, 2017
|
69,213
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
5,450,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
500,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 13, 2017
|
700,000
|
N/A
|
|